Detailansicht

Wissensnetz

Person

Yves Matthess (1975-)

Biologe

Name	Yves Matthess
Zeit	1975- (Lebensdaten)
Ort	Wittenberg (Geburtsort) Deutschland
Beruf	Biologe (charakteristischer Beruf)
Weitere Angaben	Diss. Fachbereich Biowissenschaften, Univ. Frankfurt am Main
Datensatztyp	Person
GND-Nummer	143848321
Datensatz-ID	143848321
Beteiligt an alle anzeigen A dimerization-dependent mechanism regulates enzymatic activation and nuclear entry of PLK1 PLK1 has tumor-suppressive potential in APC-truncated colon cancer cells PLK1 has tumor-suppressive potential in APC-truncated colon cancer cells Synthetic lethality in CCNE1-amplified high grade serous ovarian cancer through combined inhibition of Polo-like kinase 1 and microtubule dynamics Ligand stimulation of CD95 induces activation of Plk3 followed by phosphorylation of caspase-8 Polo-like kinase 3 and phosphoT273 caspase-8 are associated with improved local tumor control and survival in patients with anal carcinoma treated with concomitant chemoradiotherapy Funktionelle Studien zur Hemmung der Apoptose in mitotischen Zellen SKAP1 protein PH domain determines RapL membrane localization and Rap1 protein complex formation for T cell receptor (TCR) activation of LFA-1 Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells Funktionelle Studien zur Hemmung der Apoptose in mitotischen Zellen Tumor inhibition by genomically integrated inducible RNAi-cassettes

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Yves Matthess (1975-)

A dimerization-dependent mechanism regulates enzymatic activation and nuclear entry of PLK1

PLK1 has tumor-suppressive potential in APC-truncated colon cancer cells

PLK1 has tumor-suppressive potential in APC-truncated colon cancer cells

Synthetic lethality in CCNE1-amplified high grade serous ovarian cancer through combined inhibition of Polo-like kinase 1 and microtubule dynamics

Ligand stimulation of CD95 induces activation of Plk3 followed by phosphorylation of caspase-8

Polo-like kinase 3 and phosphoT273 caspase-8 are associated with improved local tumor control and survival in patients with anal carcinoma treated with concomitant chemoradiotherapy

Funktionelle Studien zur Hemmung der Apoptose in mitotischen Zellen

SKAP1 protein PH domain determines RapL membrane localization and Rap1 protein complex formation for T cell receptor (TCR) activation of LFA-1

Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells

Funktionelle Studien zur Hemmung der Apoptose in mitotischen Zellen

Tumor inhibition by genomically integrated inducible RNAi-cassettes